ReviewERJ open research2025
Bronchiectasis and sinonasal diseases: a narrative review.
Review in ERJ open research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Asthma and Sinonasal Diseases: Shared Clinical Comorbidities, Inflammatory Pathways and Management Strategies.Medical sciences (Basel, Switzerland) · 2026Review
- The importance of symptoms in bronchiectasis.European respiratory review : an official journal of the European Respiratory Society · 2026Review
- Global research trends and hotspots in bronchiectasis: a bibliometric analysis.Journal of thoracic disease · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bronchiectasis and chronic rhinosinusitis are chronic diseases of the upper and lower respiratory tract characterised by both infective and inflammatory pathways. The two share many clinical, radiological, microbiological and pathophysiological aspects. Bronchiectasis and chronic rhinosinusitis may be characterised by different endotypes, with inflammation driven by either neutrophils and/or eosinophils. Although the two conditions may coexist, the prevalence of their association remains uncertain. To date, few studies have investigated the pathogenetic relationship between these disorders, with ambiguous results obtained in heterogeneous populations. Some findings suggest that patients with both chronic rhinosinusitis and bronchiectasis may have a heavier disease burden consisting of more exacerbations, more debilitating symptoms, higher radiological severity and worse quality of life. In light of this, identification of treatable traits is crucial and patients are likely to benefit from a multidisciplinary approach involving, among others, pulmonologists, ear-nose-throat physicians, respiratory physiotherapists and allergists/immunologists.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.